Botox, Dysport, and Xeomin Are Not Interchangeable. Here Is What Actually Differs.
All three are FDA-approved botulinum toxin type A products, but they are not interchangeable and they are not all labeled for the same cosmetic uses. Here's what actually matters when you're choosing.
Elena Gorbunova
PA-C, Beauty Medica

- Botox Cosmetic, Dysport, and Xeomin are all FDA-approved botulinum toxin type A products, but their units are not interchangeable.
- Botox Cosmetic has the broadest cosmetic FDA label. Dysport and Xeomin are approved for fewer labeled cosmetic indications.
- The best choice depends more on your anatomy, your injector's technique, and your treatment goals than on brand preferences.
- If you have had one brand before, your response history is the most relevant data point.
The short answer
If you’re choosing between Botox, Dysport, and Xeomin, the honest answer is this: they’re more alike than social media makes them sound.
All three are FDA-approved prescription botulinum toxin type A products. They work by relaxing targeted muscles so expression lines soften over time. The real decision usually isn’t “Which brand is best?” It’s “Which product, dose, and injection plan make the most sense for your face?”
What they have in common
All three products are injected by a licensed medical professional. All three are used to soften dynamic lines, meaning wrinkles caused by repeated muscle movement. And all three need to be dosed and placed carefully if you want natural movement instead of that stiff, overdone look people worry about.
The other important point: you cannot compare them by unit count alone. The brands use different potency units, so a “cheaper per unit” ad does not tell you much. What matters is the total treatment plan and the quality of the injector.
Where they differ on paper
Here is the practical version of the FDA-label story:
- Botox Cosmetic is approved for frown lines, forehead lines, crow’s feet, and platysma bands.
- Dysport is approved for glabellar lines, the vertical creases between the brows.
- Xeomin is approved for upper facial lines.
That does not mean one is automatically better. It means the labels are not identical, and your injector should know exactly what they’re using, where they’re using it, and why.
What patients usually notice in real life
This is where the conversation gets muddled online.
You’ll hear that Dysport spreads more, Xeomin is “cleaner,” and Botox is the gold standard. There is some truth behind those talking points, but they get oversimplified fast. In real life, your result is shaped by several things at once:
- how the product is reconstituted
- where it’s placed
- how much is used
- how strong your muscles are
- what result you’re after
Product choice matters. It is not the only thing that matters.
Does Xeomin being “naked” matter?
Xeomin is often described as the product without accessory proteins. That’s real, and it’s part of how the brand is positioned. For most patients, the more useful question is not whether a product sounds cleaner in a brochure. It’s whether you’ve responded well to it before and whether your injector prefers it for the area being treated.
What about onset and longevity?
Some patients feel one product kicks in a little faster for them, or wears a little differently. That does happen. But it is not reliable enough to treat as a universal rule.
If you want treatment right before an event, the smarter move is to book early enough that you have room for the product to settle, rather than betting everything on a brand-specific promise.
How to think about the choice
Ask your provider:
- Which product do you recommend for my treatment area?
- Why that one instead of the others?
- What is my response history with each brand?
- What is the total expected cost, not just the cost per unit?
If the answer is basically “this one is on special this month,” that’s not a great reason.
So which one is best?
There is not a universal winner.
Botox may be the most familiar. Dysport fits well in some treatment plans. Xeomin appeals to patients who prefer its formulation or have done well with it before. But the biggest predictor of a good outcome is still thoughtful assessment, conservative dosing, and good anatomy-based injection technique.
That’s the part worth paying attention to.
- FDA: Botulinum toxin products for facial wrinkles
- Satriyasa BK. Botulinum toxin A for reducing facial wrinkles: clinical use and pharmacology. Clin Cosmet Investig Dermatol. 2019
- FDA: Postmarket safety information for botulinum toxin products
- FDA: Drug Trials Snapshot: DAXXIFY
- FDA: Drug Trials Snapshots: LETYBO
Elena Gorbunova
PA-C, Beauty Medica
PA-C, Beauty Medica
Related articles
Continue with another article from this section.

Why Aesthetic Results Depend on Shared Vision, Not Just Products
The same tools can create very different results. Patients should choose a provider whose aesthetic vision aligns with theirs.
Read article
Skin Boosters and Exosomes: What They Are, What They Are Not, and What to Ask First
Patients often arrive with a search term. This guide explains how skin boosters, exosomes, Gouri, and related treatments fit inside a broader Skin …
Read article
Your Skincare Routine Did Not Fail. Your Hormonal Environment Changed.
When hormones shift, skin behaves differently in ways your routine no longer addresses. Here is what is actually happening and which clinical …
Read article